SIDNEY ROBERTSON: Open Payments
NPI 1376313155 · HILLIARD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,495 in 155 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $1,119 · 2025 $2,495
Food & beverage: $2,495
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 25 | $499 |
| ABBVIE INC. | 31 | $430 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 28 | $411 |
| E.R. Squibb & Sons, L.L.C. | 22 | $370 |
| Otsuka America Pharmaceutical, Inc. | 13 | $189 |
| Neurocrine BioSciences, Inc. | 8 | $160 |
| Alkermes, Inc. | 13 | $160 |
| Lundbeck LLC | 5 | $84 |
| Teva Pharmaceuticals USA, Inc. | 4 | $76 |
| Axsome Therapeutics, Inc. | 3 | $66 |
Products named: VRAYLAR, CAPLYTA, COBENFY, HETLIOZ, REXULTI, INGREZZA, FANAPT, ARISTADA.
Industry payments across OH — which companies pay providers there.
